🔴 Solid Biosciences is trading 10% down today as oil and Treasury yields pressure biotech stocks

Solid Biosciences is trading 10% down at $8.02 as higher crude oil prices and Treasury yields pressure growth-oriented healthcare stocks.

• Biotech ETF XBI is down 2.04%, while the Nasdaq is down 1.33%.
• No verified company-specific announcement, FDA action, earnings release, or clinical-trial update was identified for September 23, 2026; recent company news concerned investor-conference participation.